Drug prescribing before and during pregnancy in South West France: A retrolective study

Drug Safety

Volumn 34, Issue 7, 2011, Pages 595-604

  Crespin, Sophie ^a   Bourrel, Robert ^b   Hurault Delarue, Caroline ^a   Lapeyre Mestre, Maryse ^a   Montastruc, Jean Louis ^a   Damase Michel, Christine ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

Author keywords

Pregnancy; Prescribing; Teratogenesis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IBUPROFEN; KETOPROFEN; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOID; VALPROIC ACID;

ADULT; ARTICLE; CHRONIC DISEASE; DATA BASE; DRUG CONTRAINDICATION; DRUG USE; EVALUATION; FEMALE; FETOTOXICITY; FRANCE; HUMAN; MAJOR CLINICAL STUDY; PHARMACY; PREGNANCY; PREGNANT WOMAN; PREPREGNANCY CARE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 79958794148     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11589170-000000000-00000     Document Type: Article

References (31)

1. Marimbert J. Isotretinoine orale Renforcement du Programme de Prevention des Grossesses et rappel sur la sur-venue eventuelle de troubles psychiatriques lettres aux professionnels de sante. Afssaps 2009 [online]. Available from URL: http://www.afssaps.fr/Infos-de-securite/Lettres-aux-professionnels-de-sante/ Isotretinoine-orale-Renforce ment-du-Programme-de-Prevention-des-Grossesses-et- rappel-sur-la-survenue-eventuelle-de-troubles-psychiatriques-Lettre-aux- professionnels-de-sante/(language)/fre-FR [Accessed 2011 Apr 5]
2. Duneton P. Rappel sur la contre-indication de tous les AINS a partir du 6eme mois de grossesse, lettre aux pro-fessionnels de sante. Afssaps 2003 [online]. Available from URL: http://www.afssaps.fr/Infos-de-securite/Lettres- aux-professionnels-de-sante/Rappel-sur-la-contre-indication-de-tous-les-AINS-a- partir-du-debut-du-6eme-mois-de-la-gross esse/(language)/fre-FR [Accessed 2011 Apr 15]
3. Marimbert J. Rappel sur la contre-indication des AINS a partir du debut du 6eme mois de la grossesse, quelle que soit la voie d'administration, lettre aux professionnels de sante. Afssaps 2009 [online]. Available from URL: http://www.afssaps.fr/Infos-de-securite/Lettres-aux-professionnels-de-sante/ Rappel-sur-la-contre-indication-des-AINS-a-partir-du-debut-du-6eme-mois-de-la- grossesse-quelle-que-soit-la-voie-d-administration [Accessed 2011 Apr 5]
4. Marimbert J. Rappel sur la contre-indication des antagonistes des recepteurs de l'angiotensine II (ARA II) et des inhibiteurs de l'enzyme de conversion (IEC) au cours des 2eme et 3eme trimestres de la grossesse (princeps et gener-iques), lettre aux professionnels de sante. Afssaps 2008 [online]. Available from URL: http://www.afssaps.fr/In fos-de-securite/Lettres-aux- professionnels-de-sante/Rappel-sur-la-contre-indication-des-antagonistes-des- recepteurs-de-l-angiotensine-II-ARAII-et-des-inhibiteurs-de-l-enzyme-de- conversion-IEC-au-cours-des-2eme-et-3eme-trimestres-de-la-grossesse-princeps-et- generiques/(language)/fre-FR [Accessed 2011 Apr 15]
5. Duneton P. Rappel sur la contre-indication des antagonistes des recepteurs de l'angiotensine II au cours des 2eme et 3eme trimestres de la grossesse. Afssaps 2003 [online]. Available from URL: http://www.afssaps.fr/ Infos-de-securite/Lettres-aux-professionnels-de-sante/Rappel-sur-la-contre- indication-des-antagonistes-des-recepteurs-de-l-angiotensine-II-au-cours-des- 2eme-et-3eme-trimestres-de-la-grossesse [Accessed 2011 Apr 5]
6. Dictionnaire Vidal. Issy les Moulineaux: Vidal, 2009
7. Damase-Michel C. Valproate et grossesse: effets a long terme. BIP 2005 Apr; 11: 5 [online]. Available from URL: http://www.bip31.fr/bip/bip04-2005.pdf [Accessed 2011 Apr 15]
8. Valproic acid: long-term effects on children exposed in utero. Prescrire Int 2009 Dec; 18 (104): 253-7
9. DREES. Statistique annuelle des etablissements de sante 2007 [online]. Available from URL: http://www.sae-diffusion.sante.gouv.fr/[Accessed 2011 Apr 5]
10. CNGOF recommandations pour la pratique Clinique Supplementations au cours de la grossesse (1997) [online]. Available from URL: http://www.cngof.asso.fr [Accessed 2011 May 18]
11. Gagne JJ, Maio V, Berghella V, et al. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol 2008 Nov; 64 (11): 1125-32
12. Engeland A, Bramness JG, Daltveit AK, et al. Prescription drug use among fathers and mothers before and during pregnancy: a population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 2008 May; 65 (5): 653-60 (Pubitemid 351535090)
13. Egen-Lappe V, Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004 Nov; 60 (9): 659-66 (Pubitemid 40064599)
14. Bakker MK, Jentink J, Vroom F, et al. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 2006 May; 113 (5): 559-68
15. Benoist BD. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Geneva: World Health Organization, 2008
16. Non-anaemic pregnant women should not take iron supplements. Prescrire Int 2009 Dec 18 (104): 261-262
17. Lacroix I, Hurault C, Sarramon MF, et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 2009 Aug; 65 (8): 839-46
18. Magee LA. Treating hypertension in women of child-bearing age and during pregnancy. Drug Saf 2001; 24 (6): 457-74 (Pubitemid 32458080)
19. Lam J, Polifka JE, Dohil MA. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J Am Acad Dermatol 2008 Aug; 59 (2): 295-315
20. Commission nationale de pharmacovigilance du 30 Septembre 2008: enquete officielle isotretinoine et grossesse (Roaccutane° et generiques), resultats preliminaires de l'enquete pharmaciens 26 novembre 2008. Afssaps, 2008 [online]. Available from URL: http://www.afssaps.fr/var/afssaps-site/storage/ original/application/44c88f6d7ce134fc2c 4f0a337ce33109.pdf [Accessed 2011 Apr 15]
21. Hurault C, Lacroix I, Bourrel R, et al. Writing and dispensing of NSAID prescriptions in late pregnancy: impact of health authorities' advice [in French]. Presse Med 2008 May; 37 (5 Pt 1): 767-74
22. Bouissou A, Glorieux I, Dulac Y, et al. Antenatal closure of ductus arteriosus following maternal intoxication by ni-flumic acid [in French]. Arch Pediatr 2006; 13 (1): 48-50 (Pubitemid 43052620)
23. Damase-Michel C, Christaud J, Berrebi A, et al. What do pregnant women know about non-steroidal anti-inflammatory drugs? Pharmacoepidemiol Drug Saf 2009 Nov; 18 (11): 1034-8
24. Damase-Michel C, Pichereau J, Pathak A, et al. Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area. Pharm Pract 2008 Jan-Mar; 6: 15-9 (Pubitemid 351586580)
25. Bowen ME, Ray WA, Arbogast PG, et al. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Am J Obstet Gynecol 2008 Mar; 198 (3): 291.e1-5
26. Tomson T, Hiilesmaa V. Epilepsy in pregnancy. BMJ 2007 Oct 13; 335 (7623): 769-73 (Pubitemid 47612634)
27. Martinez-Frias ML, Rodriguez-Pinilla E. First-trimester exposure to topical tretinoin: its safety is not warranted [letter] Teratology 1999 Jul; 60 (1): 5 (Pubitemid 29338847)
28. Topical retinoids during pregnancy (continued). Prescrire Int 2005 Jun; 14 (77): 100-1
29. Torloni M, Cordioli E, Zamith M, et al. Reversible constriction of the fetal ductus arteriosus after maternal use of topical diclofenac and methyl salicylate. Ultrasound Obstet Gynecol 2006; 27 (2): 227-9 (Pubitemid 43733744)
30. Coulomb A, Baumelou A. Situation de l'automedication en France et perspectives d'evolution [online]. Available from URL: http://lesrapports. ladocumentationfrancaise.fr/BRP/074000030/0000.pdf [Accessed 2011 Apr 5]
31. Olesen C, Sondergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology 2001 Sep; 12 (5): 497-501 (Pubitemid 32761987)